A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
11/2002
11/13/2002	CN1379817A Composition and methods for increasing cholesterol efflux and raising HDL using ATP binding cassettte ttansporter protein ABC1
11/13/2002	CN1379816A Human G-protein coupled receptor
11/13/2002	CN1379784A Production of polymorphic forms I and II of finasteride by complexation with group I or II metal
11/13/2002	CN1379781A Novel oligosaccharides, preparation method and pharmaceutical composition containing same
11/13/2002	CN1379777A Amino-triazolopyridine derivatives
11/13/2002	CN1379776A Pharmaceutical compositions containing thiazolidinedione derivatives and process for their preparation
11/13/2002	CN1379775A Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
11/13/2002	CN1379774A Compounds
11/13/2002	CN1379772A Substituted indoles for modulating NFKB activity
11/13/2002	CN1379769A Novel composition and method or stabilizing same
11/13/2002	CN1379768A Improved aqueous solubility pharmaceutical formulations
11/13/2002	CN1379767A Isoxazolecarboxamide derivatives
11/13/2002	CN1379766A Benzoic acid derivatives for treatment of diabetes mellitus
11/13/2002	CN1379765A Benzodiazepine derivatives usable as parental metabolic glutamate receptor antagonist
11/13/2002	CN1379764A Benzodiazepine derivatives
11/13/2002	CN1379763A Pyrazoloanthrone and derivatives thereof as JNK inhibitors and their compositions
11/13/2002	CN1379762A Beta substituted metalloprotease inhibitors
11/13/2002	CN1379761A Condensed indoline derivatives and their use as 5HT, in particular 5HT2C receptor ligands
11/13/2002	CN1379756A Substituted nor bornylamino derivatives, method for production thereof, use thereof as medicament or diagnostic reagent medicaments containing said compounds
11/13/2002	CN1379755A Substituted 2-dialkylamino alkylbiphenyl derivatives
11/13/2002	CN1379752A Aromatic di-ceto-derivatives use as glucose-6-phosphate translocase inhibitors
11/13/2002	CN1379686A Composition comprising tramadol material and anticonvulsant drug
11/13/2002	CN1379684A Treating prostate cancer with anti-ErbB2 antibodies
11/13/2002	CN1379677A Method of preventing adhesions with absorbable polyoxaesters
11/13/2002	CN1379676A Blood plasma replacement composition
11/13/2002	CN1379675A 24-hydroxyvitamin D, analogs and use thereof
11/13/2002	CN1379674A Ciclesonide contained pharmaceutical composition for application to mucosa
11/13/2002	CN1379673A Ciclesonide-containing aqueous pharmaceutical composition
11/13/2002	CN1379672A Highly selective norepinephrine reuptake inhibitors and methods of using same
11/13/2002	CN1379671A Treating sleep disorders using desloratadine
11/13/2002	CN1379670A FT-raman spectroscopic measurement of omeprazole isomer ratio in composition
11/13/2002	CN1379669A Valdecoxib compositions
11/13/2002	CN1379668A 3(5)-ureido-pyrazole derivatives, process for their preparation and their use as antitumor agents
11/13/2002	CN1379667A Compositions for prevention and treatment of cold and influenza-like symptoms and their methods of use
11/13/2002	CN1379666A Non-peptide GnRH agents, methods and intermediates for their preparation
11/13/2002	CN1379665A Method for delivering benzidine prostaglandins by inhalation
11/13/2002	CN1379664A Activation and protection of cytotoxic lymphocytes using reactive oxygen metabolite inhibitor
11/13/2002	CN1379626A Food product and process for manufacturing same
11/13/2002	CN1379624A Antiviral compositions for tissue paper
11/13/2002	CN1379149A Weight-lossing fabric and its preparing process
11/13/2002	CN1379047A Match of organic medicine and beta-cyclodextrin derivative and its preparing process
11/13/2002	CN1379040A Soluble inorganic salt of Huanweihuangyangxing D, its preparing process and medicine containing it
11/13/2002	CN1379019A Composite vegetative amino acid and its preparing process
11/13/2002	CN1378865A Medicine coated support frame of blood vessel
11/13/2002	CN1378858A Medicine for preventing or treating osteoporosis and its preparing process and application
11/13/2002	CN1378852A Detoxicating ointment for treating burn and scald and its preparing process
11/13/2002	CN1378842A Ointment for treating dermatopathy
11/13/2002	CN1378841A Medicine for treating rhinitis
11/13/2002	CN1378840A Slow-releasing composition of estrogen medicine and its preparing process
11/13/2002	CN1378839A 'Runlizi' tablet
11/13/2002	CN1378838A Process for preparing medicine to prevent and treat recurrence of heroin dependent patient
11/13/2002	CN1378837A Application of danshinolic acid compounds in preparing medicines
11/13/2002	CN1378836A Exterior-applied article for losing weight
11/13/2002	CN1378789A Application of medical feed for systematic treating fish disease
11/13/2002	CN1094126C Pyrroloazepine compounds
11/13/2002	CN1094060C Medicinal composition for treating cough and preparation process thereof
11/12/2002	US6480405 Full-wave rectifier
11/12/2002	US6479725 Method of treatment of a wound or incision
11/12/2002	US6479692 Reacting a keto-carboxy derivative with a substituted aniline to form an amide and treating to form an acylanilide
11/12/2002	US6479679 Two-step conversion of protected taxane ester to paclitaxel
11/12/2002	US6479676 OxiranEcarboxylic acids for the treatment of diabetes
11/12/2002	US6479673 Antiretroviral enantiomeric nucleotide analogs
11/12/2002	US6479670 Selective retinoid acid receptor agonists
11/12/2002	US6479666 Phenyl-keto-imidazolidine thioamide derivatives
11/12/2002	US6479663 Intermediates useful for the preparation of antihistaminic piperidine derivatives
11/12/2002	US6479662 Antitumor dibenzofluorene derivatives
11/12/2002	US6479660 Process for the preparation of anti-malarial drugs
11/12/2002	US6479659 Improved process and novel intermediates to endothelin receptor antagonists
11/12/2002	US6479655 TNF receptor promoter
11/12/2002	US6479654 Forms of the angiogenic factor vascular endothelial cell growth factor: VEGF
11/12/2002	US6479643 Single chain analogs of the TGF-β superfamily (morphons)
11/12/2002	US6479633 Chemokine alpha 2
11/12/2002	US6479556 Adding polyoxyethylene sorbitan ester to an ophthalmic formulation containing a terpenoid such as camphor, borneol, and menthol to improve wettability
11/12/2002	US6479555 Method for inducing hepatic fibrosis by repeated administration of allylalcohol
11/12/2002	US6479554 Immunotherapeutic agents
11/12/2002	US6479553 Use of certain affinity NMDA antagonists as antidepressants
11/12/2002	US6479551 Treatment of migraine headache
11/12/2002	US6479549 Alzheimer's disease; antiischemic agents
11/12/2002	US6479548 Substituted stilbenes as glucose uptake enhancers
11/12/2002	US6479547 Method of treating an infection by enhancing the effectiveness of the human immune system
11/12/2002	US6479546 Allosteric inhibitors of lipoxygenase
11/12/2002	US6479545 Formulation for menopausal women
11/12/2002	US6479544 Therapeutic combinations of fatty acids
11/12/2002	US6479541 Amiodarone-containing parenteral administration
11/12/2002	US6479540 Compositions of tocol-soluble therapeutics
11/12/2002	US6479539 Procyanidin compositions and methods for making the same
11/12/2002	US6479538 Cyclic ether vitamin D3 compounds, 1α(OH)3-EPI-vitamin D3 compounds and uses thereof
11/12/2002	US6479535 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-indole and estrogen formulations
11/12/2002	US6479534 Indoline derivatives and method of treating obesity
11/12/2002	US6479533 Methods and compositions for the protection of mitochondria
11/12/2002	US6479532 Antifungal compositions
11/12/2002	US6479531 Gastrin and cholecystokinin receptor ligands
11/12/2002	US6479530 Substituted 4(5)-(1-indanyl,-indanylmethyl, indanylmethylen), 4(5)-(1-(1,2,3,4-tetrahydronaphthyl, -naphthylmethyl and naphthylmethylen)imidazoles; hypotensive, ischemic and anxiolytic agents; nervous and muscular system disorders
11/12/2002	US6479529 Antioxidant stabilizer system for pharmaceutical formulations
11/12/2002	US6479528 Methods for inhibiting or reversing tau filament formation polymerization
11/12/2002	US6479527 Bicyclic pyrrole derivatives as MCP-1 inhibitors
11/12/2002	US6479526 Pharmaceutical composition for inhibiting the growth of viruses and cancers
11/12/2002	US6479524 To prolong the thrombin time
11/12/2002	US6479523 Achieved by electrical stimulation of the vagus nerve and administration of a combination of drugs including: an acetylcholinesterase inhibitor, a beta-adrenergic receptor blocker, and a calcium channel blocker
11/12/2002	US6479520 Method of treating a patient having precancerous lesions with phenyl pyridinone derivatives

1 ... 5653 5654 5655 5656 5657 5658 5659 5660 5661 5662 5663 5664 5665 5666 5667 5668 5669 5670 5671 5672 5673 ... 7860